The public comment period docket (docket FDA-2018-N-3240) and the FDA's GLP-1 consumer safety page are directly accessible at fda.gov
Oh, gosh, things could go bad
Abnousian, A., Vasquez, J., Sasaninia, K., Kelley, M., & Venketaraman, V
In contrast, findings of de Vries and DeLorey showed that increasing the NO bioavailability through acute (2.5 h) the BR supplement consumption does not change the sympathetic vasoconstrictor responsiveness to sympathoexcitation at rest or during training (43)
Chronic heavy alcohol consumption impairs B12 status through poor dietary intake, malabsorption, and liver disease
10.1016/j.ijbiomac.2022.05.150 55 ZhengZ.ZongY.MaY.TianY.PangY.ZhangC.et al (2024)